Advertisement

Kanamycin Sulfate Injection

[31 January 2013]

Products Affected - Description

Kanamycin sulfate 1 gram/3 mL vials (NDC 63323-0359-03), APP

Reason for the Shortage

APP was unable to obtain raw materials to manufacture kanamycin injection.

Available Products

No presentations are available.

Estimated Resupply Dates

APP has kanamycin on long-term back order and the company cannot estimate a release date.

Related Shortages

Updated

January 31, 2013; January 2, 2013; September 28, 2012; June 18, 2012; March 30, 2012; January 23, 2012; December 13, 2011; November 28, 2011; September 7, 2011; June 8, 2011; March 31, 2011; February 8, 2011; November 19, 2010; September 30, 2010; July 28, 2010; May 28, 2010; April 2, 2010; February 22, 2010; January 4, 2010; December 9, 2009; October 26, 2009; September 14, 2009; August 7, 2009; July 7, 2009; May 20, 2009; May 12, 2009; February 26, 2009.  University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity

Get the latest updates on ASHP's advocacy activity on drug shortages.



In Cooperation With

University of Utah & Novation
Advertisement